EUVIMEDEUVIMED entdecken
Crossref

Induction of apoptotic endonuclease EndoG with DNA-damaging agents initiates alternative splicing of telomerase catalytic subunit hTERT and inhibition of telomerase activity hTERT in human CD4+ and CD8+ T-lymphocytes

D D Zhdanov, D A Vasina, V S Orlova, E V Orlova, D V Grishin, Yu A Gladilina, M V Pokrovskaya, S S Aleksandrova, N N Sokolov

Biomeditsinskaya Khimiya · 2017-07 · 63 (4) · 296-305

DOI: 10.18097/pbmc20176304296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomeditsinskaya Khimiya, 2017. Verfasst von D D Zhdanov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Chemistry, Moscow, Russia. Hauptthemen laut MEDLINE: Alternative Splicing, DNA Damage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activity of telomerase catalytic subunit hTERT (human Telomerase Reverse Transcriptase) can be regulated by alternative splicing of its mRNA. At present time exact mechanism of hTERT splicing is not fully understood. Apoptotic endonuclease EndoG is known to participate this process. EndoG expression is induced by DNA damages. The aim of this work was to investigate the ability of DNA-damaging agents with different mechanism of action to induce EndoG expression and inhibit telomerase activity due to the activation of hTERT alternative splicing in normal activated human CD4+ and CD8+ T-lymphocytes. All investigated DNA-damaging agents were able to induce EndoG expression. Cisplatin, a therapeutic compound, producing DNA cross-links induced the highest level of DNA damages and EndoG expression. Incubation of CD4+ and CD8+ T-cells with cisplatin caused the changes in proportion of hTERT splice variants and inhibition of telomerase activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingDNA DamageCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedCisplatinEndodeoxyribonucleasesHumansTelomerase

Stichwörter der Autor:innen

DNA damageEndoGT-lymphocytesalternative splicinghTERTtelomerase

Substanzen

TERT protein, humanTelomeraseEndodeoxyribonucleasesendonuclease GCisplatin

Autor:innen und Institutionen

  • Institute of Biomedical Chemistry, Moscow, Russia.
  • Peoples Friendship University of Russia, Moscow, Russia.
  • Institute of Theoretical and Experimental Biophysics, Moscow, Russia.

Zitieren

APA

Zhdanov, D. D., Vasina, D. A., Orlova, V. S., Orlova, E. V., Grishin, D. V., Gladilina, Y. A., Pokrovskaya, M. V., Aleksandrova, S. S., & Sokolov, N. N. (2017). Induction of apoptotic endonuclease EndoG with DNA-damaging agents initiates alternative splicing of telomerase catalytic subunit hTERT and inhibition of telomerase activity hTERT in human CD4+ and CD8+ T-lymphocytes. Biomeditsinskaya Khimiya, 63(4), 296-305. https://doi.org/10.18097/pbmc20176304296

Vancouver

Zhdanov DD, Vasina DA, Orlova VS, Orlova EV, Grishin DV, Gladilina YA, et al. Induction of apoptotic endonuclease EndoG with DNA-damaging agents initiates alternative splicing of telomerase catalytic subunit hTERT and inhibition of telomerase activity hTERT in human CD4+ and CD8+ T-lymphocytes. Biomeditsinskaya Khimiya. 2017;63(4):296-305. doi:10.18097/pbmc20176304296

BibTeX
@article{Zhdanov2017,
  author = {Zhdanov, D D and Vasina, D A and Orlova, V S and Orlova, E V and Grishin, D V and Gladilina, Yu A and Pokrovskaya, M V and Aleksandrova, S S and Sokolov, N N},
  title = {Induction of apoptotic endonuclease EndoG with DNA-damaging agents initiates alternative splicing of telomerase catalytic subunit hTERT and inhibition of telomerase activity hTERT in human CD4+ and CD8+ T-lymphocytes},
  journal = {Biomeditsinskaya Khimiya},
  year = {2017},
  volume = {63},
  number = {4},
  pages = {296--305},
  doi = {10.18097/pbmc20176304296}
}
Kostenlos starten →